Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electron Diffraction of 3D Molecular Crystals.
Saha A, Nia SS, Rodríguez JA. Saha A, et al. Chem Rev. 2022 Sep 14;122(17):13883-13914. doi: 10.1021/acs.chemrev.1c00879. Epub 2022 Aug 15. Chem Rev. 2022. PMID: 35970513 Free PMC article. Review.
Characterization of Reactive Organometallic Species via MicroED.
Jones CG, Asay M, Kim LJ, Kleinsasser JF, Saha A, Fulton TJ, Berkley KR, Cascio D, Malyutin AG, Conley MP, Stoltz BM, Lavallo V, Rodríguez JA, Nelson HM. Jones CG, et al. Among authors: saha a. ACS Cent Sci. 2019 Sep 25;5(9):1507-1513. doi: 10.1021/acscentsci.9b00403. Epub 2019 Sep 6. ACS Cent Sci. 2019. PMID: 31572777 Free PMC article.
Ab Initio Determination of Peptide Structures by MicroED.
Zee CT, Saha A, Sawaya MR, Rodriguez JA. Zee CT, et al. Among authors: saha a. Methods Mol Biol. 2021;2215:329-348. doi: 10.1007/978-1-0716-0966-8_17. Methods Mol Biol. 2021. PMID: 33368013 Free PMC article.
Beyond MicroED: Ab Initio Structure Elucidation using 4D-STEM.
Saha A, Pattison A, Mecklenburg M, Brewster A, Ercius P, Rodriguez JA. Saha A, et al. Microsc Microanal. 2023 Jul 22;29(Supplement_1):309-310. doi: 10.1093/micmic/ozad067.143. Microsc Microanal. 2023. PMID: 37613469 No abstract available.
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3.
Goetz MP, Toi M, Huober J, Sohn J, Trédan O, Park IH, Campone M, Chen SC, Manso LM, Paluch-Shimon S, Freedman OC, O'Shaughnessy J, Pivot X, Tolaney SM, Hurvitz S, Llombart-Cussac A, André V, Saha A, van Hal G, Shahir A, Iwata H, Johnston SRD. Goetz MP, et al. Among authors: saha a. Ann Oncol. 2024 May 8:S0923-7534(24)00139-X. doi: 10.1016/j.annonc.2024.04.013. Online ahead of print. Ann Oncol. 2024. PMID: 38729566
2,857 results